Multiple Myeloma section

Multiple Myeloma News & Features

Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials

Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials

[Oncotargets and Therapy] This research examines the efficacy and safety of bortezomib-based vs non-bortezomib-based post-transplantation therapy in patients with multiple myeloma.

Leisure sitting time associated with increased risk of cancer in women

Leisure sitting time associated with increased risk of cancer in women

Researchers have found that spending more leisure time sitting was associated with an increased risk for developing cancer in women.

Panobinostat combination demonstrates benefit in relapsed/refractory multiple myeloma

Panobinostat combination demonstrates benefit in relapsed/refractory multiple myeloma

Patients with relapsed or refractory myeloma experience the most benefit from panobinostat plus bortezomib and dexamethasone.

Injected immune cells found safe for patients with multiple myeloma

Injected immune cells found safe for patients with multiple myeloma

Researchers have reported safely using immune cells grown from patients' own bone marrow to treat multiple myeloma, according to clinical trial data.

Adding elotuzumab to myeloma treatment decreases risk of disease progression

Adding elotuzumab to myeloma treatment decreases risk of disease progression

Addition of elotuzumab significantly reduced risk of disease progression in relapsed or refractory multiple myeloma.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs